{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:05:27Z","timestamp":1778918727464,"version":"3.51.4"},"reference-count":18,"publisher":"American Society of Consultant Pharmacists","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2013,10,1]]},"DOI":"10.4140\/tcp.n.2013.661","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T04:11:13Z","timestamp":1381896673000},"page":"661-669","source":"Crossref","is-referenced-by-count":8,"title":["Escitalopram-Associated Acute Urinary Retention"],"prefix":"10.4140","volume":"28","author":[{"given":"Dominick","family":"Trombetta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2013,10,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"CA Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"2","unstructured":"American Geriatric Society, Beers criteria for potentially inappropriate medication use in older adults. Available at http:\/\/www.americangeriatrics.org\/health_care_professionals\/clinical_practice\/clinical_guidelines_recommendations\/2012. Accessed December 15, 2012. <a target=\"_blank\" href='http:\/\/www.americangeriatrics.org\/health_care_professionals\/clinical_practice\/clinical_guidelines_recommendations\/2012'>http:\/\/www.americangeriatrics.org\/health_care_professionals\/clinical_practice\/clinical_guidelines_recommendations\/2012<\/a>"},{"key":"3","unstructured":"Drug interaction results. Micromedex [monograph on the internet]. Available at http:\/\/emmerson.csc.wilkes.edu:2083\/micromedex2\/librarian\/PFDefaultActionId\/evidencexpert.ShowDrugInteractionsResults. Accessed December 15, 2012. <a target=\"_blank\" href='http:\/\/emmerson.csc.wilkes.edu:2083\/micromedex2\/librarian\/PFDefaultActionId\/evidencexpert.ShowDrugInteractionsResults'>http:\/\/emmerson.csc.wilkes.edu:2083\/micromedex2\/librarian\/PFDefaultActionId\/evidencexpert.ShowDrugInteractionsResults<\/a>"},{"key":"4","unstructured":"Escitalopram. Lexi-Drugs: Lexicomp [monograph on the Internet]. Available at http:\/\/emmerson.csc.wilkes.edu:2065\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6846. Accessed August 8, 2012. <a target=\"_blank\" href='http:\/\/emmerson.csc.wilkes.edu:2065\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6846'>http:\/\/emmerson.csc.wilkes.edu:2065\/lco\/action\/doc\/retrieve\/docid\/patch_f\/6846<\/a>"},{"key":"5","unstructured":"Escitalopram. Drug Facts and Comparisons: E answers [monograph on the Internet]. Available at http:\/\/emmerson.csc.wilkes.edu:2074\/MonoDisp.aspx?monoID=fandc-hcp13922&quick=350816%7c2&search=350816%7c2&isstemmed=True#firstMatch. Accessed August 8, 2012. <a target=\"_blank\" href='http:\/\/emmerson.csc.wilkes.edu:2074\/MonoDisp.aspx?monoID=fandc-hcp13922&quick=350816%7c2&search=350816%7c2&isstemmed=True#firstMatch'>http:\/\/emmerson.csc.wilkes.edu:2074\/MonoDisp.aspx?monoID=fandc-hcp13922&quick=350816%7c2&search=350816%7c2&isstemmed=True#firstMatch<\/a>"},{"key":"6","unstructured":"Escitalopram oxalate. Micromedex [monograph on the Internet]. Available at http:\/\/emmerson.csc.wilkes.edu:2083\/micromedex2\/librarian\/ND_T\/evidencexpert\/ND_PR\/evidencexpert\/CS\/336389\/ND_AppProduct\/evidencexpert\/DUPLICATIONSHIELDSYNC\/4B92A5\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_P\/evidencexpert\/PFActionId\/evidencexpert.DisplayDrugpointDocument?docId=926990&contentSetId=100&title=Escitalopram+Oxalate&servicesTitle=Escitalopram+Oxalate&topicId=mechanismOfActionPharmacokineticsSection&subtopicId=null. Accessed August 8, 2012. <a target=\"_blank\" href='http:\/\/emmerson.csc.wilkes.edu:2083\/micromedex2\/librarian\/ND_T\/evidencexpert\/ND_PR\/evidencexpert\/CS\/336389\/ND_AppProduct\/evidencexpert\/DUPLICATIONSHIELDSYNC\/4B92A5\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_P\/evidencexpert\/PFActionId\/evidencexpert.DisplayDrugpointDocument?docId=926990&contentSetId=100&title=Escitalopram+Oxalate&servicesTitle=Escitalopram+Oxalate&topicId=mechanismOfActionPharmacokineticsSection&subtopicId=null'>http:\/\/emmerson.csc.wilkes.edu:2083\/micromedex2\/librarian\/ND_T\/evidencexpert\/ND_PR\/evidencexpert\/CS\/336389\/ND_AppProduct\/evidencexpert\/DUPLICATIONSHIELDSYNC\/4B92A5\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_P\/evidencexpert\/PFActionId\/evidencexpert.DisplayDrugpointDocument?docId=926990&contentSetId=100&title=Escitalopram+Oxalate&servicesTitle=Escitalopram+Oxalate&topicId=mechanismOfActionPharmacokineticsSection&subtopicId=null<\/a>"},{"key":"7","unstructured":"Lexapro [package insert]. Available at http:\/\/www.frx.com\/pi\/lexapro_pi.pdf. Accessed August 20, 2012. <a target=\"_blank\" href='http:\/\/www.frx.com\/pi\/lexapro_pi.pdf'>http:\/\/www.frx.com\/pi\/lexapro_pi.pdf<\/a>"},{"key":"8","unstructured":"Urinary Retention. DynaMed: powered by EBSCOhost [monograph on the Internet]. Available at http:\/\/emmerson.csc.wilkes.edu:2060\/dynamed\/detail?vid=5&hid=10&sid=7f3030c7-ed9f-4030-a3a6b357b7794c92%40sessionmgr10&bdata=JnNpdGU9ZHluYW1lZC1saXZlJnNjb3BlPXNpdGU%3d#db=dme&AN=114581. Accessed August 8, 2012. <a target=\"_blank\" href='http:\/\/emmerson.csc.wilkes.edu:2060\/dynamed\/detail?vid=5&hid=10&sid=7f3030c7-ed9f-4030-a3a6b357b7794c92%40sessionmgr10&bdata=JnNpdGU9ZHluYW1lZC1saXZlJnNjb3BlPXNpdGU%3d#db=dme&AN=114581'>http:\/\/emmerson.csc.wilkes.edu:2060\/dynamed\/detail?vid=5&hid=10&sid=7f3030c7-ed9f-4030-a3a6b357b7794c92%40sessionmgr10&bdata=JnNpdGU9ZHluYW1lZC1saXZlJnNjb3BlPXNpdGU%3d#db=dme&AN=114581<\/a>"},{"key":"9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2165\/00002018-200831050-00002","article-title":"Drug-induced urinary retention: incidence, management and prevention","volume":"31","author":"KM Verhamme","year":"2008","journal-title":"Drug Saf"},{"key":"10","first-page":"530","volume-title":"Stahl's Essential Psychopharmacology Neuroscientific Basis and Practical Applications","author":"S Stahl","year":"2008"},{"key":"11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00192-006-0241-4","article-title":"Urinary hesitancy and retention during treatment with sertraline","volume":"18","author":"L Lowenstein","year":"2007","journal-title":"Int Urogynecol J"},{"key":"12","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2165\/00003495-200363230-00003","article-title":"CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention","volume":"63","author":"KE Anderson","year":"2003","journal-title":"Drugs"},{"key":"13","doi-asserted-by":"crossref","DOI":"10.1016\/j.genhosppsych.2010.04.002","article-title":"Urinary retention with a high dose of escitalopram","volume":"32","author":"A Garakani","year":"2010","journal-title":"Gen Hosp Psychiatry"},{"key":"14","unstructured":"Lexapro (escitalopram oxalate) tablets and oral solution. U.S Food and Drug Administration: Safety [homepage on the Internet]. October 2008. Available at http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/Safety-RelatedDrugLabelingChanges\/ucm122243.htm. Accessed August 8, 2012. <a target=\"_blank\" href='http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/Safety-RelatedDrugLabelingChanges\/ucm122243.htm'>http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/Safety-RelatedDrugLabelingChanges\/ucm122243.htm<\/a>"},{"key":"15","unstructured":"Abate R. DMETS medication error post marketing safety review: cymbalta. FDA: Division of medication errors and technical support office of surveillance and epidemology [homepage on the Internet]. March 2007. Available at http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm103473pdf. Accessed August 8, 2012. <a target=\"_blank\" href='http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm103473pdf'>http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm103473pdf<\/a>"},{"key":"16","unstructured":"Drug Development and Drug Interactions: Table of Substrates, Inhibitors, and Inducers. Available at http:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/developmentresources\/druginteractionslabeling\/ucm093664.htm. Accessed August 21, 2012. <a target=\"_blank\" href='http:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/developmentresources\/druginteractionslabeling\/ucm093664.htm'>http:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/developmentresources\/druginteractionslabeling\/ucm093664.htm<\/a>"},{"key":"17","unstructured":"Jackowski L, Rowett D, Scheurer D. Diagnosing and treating urinary incontinence: why your patients don't have to go with the flow. The Alosa Foundationc2010; used with permission. Available at: http:\/\/www.rxfacts.org\/pdf\/Incontinence%20ev%20doc%20FINAL%203.17.10%20v2.pdf. Accessed August 27, 2013. <a target=\"_blank\" href='http:\/\/www.rxfacts.org\/pdf\/Incontinence%20ev%20doc%20FINAL%203.17.10%20v2.pdf'>http:\/\/www.rxfacts.org\/pdf\/Incontinence%20ev%20doc%20FINAL%203.17.10%20v2.pdf<\/a>"},{"key":"18","first-page":"1711","article-title":"Comparison of three algorithms used to evaluate adverse drug reactions","volume":"43","author":"DJ Michel","year":"1986","journal-title":"Am J Hosp Pharm"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T23:57:14Z","timestamp":1498089434000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2013\/00000028\/00000010\/art00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10,1]]}},"alternative-id":["C0214L6P2245861M"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2013.661","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,1]]}}}